Clinical Trial Update: 4SCAR-CD44v6 T Cell Therapy Targeting Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on 4SCAR-CD44v6 T cell therapy targeting cancers that are CD44v6 positive, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancers

Drugs mentioned

• 4SCAR-CD44v6 T cell therapy

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Cancers Which Are CD44v6 Positive | Phase 1, Phase 2 | Status: UNKNOWN